• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 6
  3. Author

Online ISSN: 2515-8260

Volume9, Issue6

ROLE OF BETA BLOCKERS AND ASSOCIATED FRACTURE RISK IN INDIAN SUBJECTS WITH PRIMARY OSTEOPOROSIS

    Dr. B. Shobharani, Dr. P. Swathi

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 6, Pages 177-185

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: Osteoporosis leads to an increase in bone fragility with a decrease in bone mass. Literature data reports a decreased risk of fracture and a higher bone mineral density in subjects on beta blockers. However, few literature studies reported no effect of non-selective or selective beta blockers on fracture risk in osteoporosis subjects.
Aim: The present study aimed to assess the effect of non-selective and selective beta-blockers on fracture risk in Indian subjects with osteoporosis.
Methods: 120 subjects with osteoporosis from both genders were divided into 3 groups using cardio-selective beta-blocker (CSBB), NSBB (non-selective beta-blocker) group, and a control group. In all the subjects, bone turnover markers, BMD (bone mineral density), FR (fracture risk), and T-scores were assessed and results were formulated.
Results:  After 6 months of assessment, it was seen that mean T-scores had a significant difference between the three groups. Bone mineral density was significantly higher in NSBB (non-selective beta-blockers) receiving group compared to the control group. Fracture risk was statistically lesser in CSBB and NSBB groups. Also, in comparison to the control group, lesser bone turnover markers were seen in both NSBB and CSBB groups.
Conclusion: CSBB and NSBB can help in improving bone mineral density with decrease bone turnover markers and fracture risk in subjects with osteoporosis. NSBB has a more pronounced effect on reducing fracture risk at all three studied locations. Also, a significant reduction in bone turnover markers was seen particularly in s-CTX compared to the CSBB group.
Keywords:
    Beta-blockers bone fracture bone mineral density Bone turnover markers Fracture risk
  • PDF (212 K)
  • XML
(2022). ROLE OF BETA BLOCKERS AND ASSOCIATED FRACTURE RISK IN INDIAN SUBJECTS WITH PRIMARY OSTEOPOROSIS. European Journal of Molecular & Clinical Medicine, 9(6), 177-185.
Dr. B. Shobharani, Dr. P. Swathi. "ROLE OF BETA BLOCKERS AND ASSOCIATED FRACTURE RISK IN INDIAN SUBJECTS WITH PRIMARY OSTEOPOROSIS". European Journal of Molecular & Clinical Medicine, 9, 6, 2022, 177-185.
(2022). 'ROLE OF BETA BLOCKERS AND ASSOCIATED FRACTURE RISK IN INDIAN SUBJECTS WITH PRIMARY OSTEOPOROSIS', European Journal of Molecular & Clinical Medicine, 9(6), pp. 177-185.
ROLE OF BETA BLOCKERS AND ASSOCIATED FRACTURE RISK IN INDIAN SUBJECTS WITH PRIMARY OSTEOPOROSIS. European Journal of Molecular & Clinical Medicine, 2022; 9(6): 177-185.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 58
  • PDF Download: 61
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus